← back to search

Tristram D. Bahnson

Duke University Hospital · US
Area of research
Cardiology and Cardiovascular Medicine · Economics and Econometrics
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Cardiac pacing and defibrillation studies, and Cardiac electrophysiology and arrhythmias.
h-index
34
citations
6,562
works
108
NIH funding
primary concept
Medicine
email

Recent publications

Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center Experience.
2025cited by 1position: contributordoi
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial
Circulation Arrhythmia and Electrophysiology 2024cited by 16position: middledoi
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.
2024cited by 10position: contributordoi
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
2023cited by 13position: contributordoi
Use of Ripple mapping to enhance localization and ablation of outflow tract premature ventricular contractions.
2023cited by 2position: contributordoi
Reply to: Two ripples in a pond: The subtleties of mapping observations in localizing PVC sites.
2023cited by 0position: contributordoi
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.
2022cited by 84position: contributordoi
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
2022cited by 51position: contributordoi
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA
EP Europace 2022cited by 35position: middledoi
Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection.
2022cited by 26position: contributordoi
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
2022cited by 24position: contributordoi
Is there a mortality benefit of atrial fibrillation ablation?
2022cited by 0position: contributordoi
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation
JAMA 2019cited by 1,451position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2022–2025)Jeanne E. Poole · University of Washington7 papers (2022–2024)Douglas L. Packer · St. Mary's Medical Center6 papers (2022–2024)Jonathan P. Piccini · iRhythm (United States)6 papers (2022–2025)Daniel B. Mark · Agency for Healthcare Research and Quality5 papers (2022–2024) · 5 papers (2022–2024)Hussein R. Al-Khalidi · Keio University5 papers (2022–2024)Kevin P. Jackson · Duke Medical Center4 papers (2022–2025)Albert Y. Sun · Duke Medical Center4 papers (2022–2025) · 4 papers (2022–2024) · 4 papers (2022–2023) · 3 papers (2022–2022)Melanie R. Daniels · Duke Medical Center3 papers (2022–2024)Thomas Jared Bunch · University of Colorado Denver2 papers (2022–2024)Larry R. Jackson · Clinical Research Institute2 papers (2022–2025)Andrea M. Russo · Radboud University Medical Center2 papers (2022–2023)Kelly Arps · Duke University Hospital2 papers (2023–2023) · 2 papers (2022–2025) · 2 papers (2022–2025)James P. Daubert · Duke University2 papers (2022–2025)